Phase 2 study of Nab-Paclitaxel for patients with previously treated EGFR wild-type non-small-cell lung cancer.
Phase 2
- Conditions
- on-small-cell lung cancer
- Registration Number
- JPRN-UMIN000018233
- Lead Sponsor
- Shimane university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1)Brain metastasis with the symptom 2)Active interstitial pneumonia or pulmonary fibrosis 3)Body fluid retention to need waste fluid 4)Hypersensitivity for paclitaxel or albumin 5)Pregnant or nursing female or man without the intention of the contraception 6)Active concomitant malignancy 7)Inappropriate patients for this study judged by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method